KBC Group NV Sells 1,235 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

KBC Group NV decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 423,504 shares of the medical equipment provider’s stock after selling 1,235 shares during the quarter. Intuitive Surgical accounts for 0.6% of KBC Group NV’s portfolio, making the stock its 24th biggest holding. KBC Group NV’s holdings in Intuitive Surgical were worth $221,052,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of ISRG. Bennett Selby Investments LP grew its position in Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after purchasing an additional 17 shares during the last quarter. LVW Advisors LLC grew its holdings in shares of Intuitive Surgical by 1.3% during the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after buying an additional 19 shares during the last quarter. Wesbanco Bank Inc. increased its position in shares of Intuitive Surgical by 1.6% in the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after acquiring an additional 19 shares during the period. Hazlett Burt & Watson Inc. raised its stake in Intuitive Surgical by 5.8% in the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock worth $177,000 after acquiring an additional 20 shares during the last quarter. Finally, Mitchell Mcleod Pugh & Williams Inc. lifted its position in Intuitive Surgical by 4.1% during the 3rd quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock worth $247,000 after acquiring an additional 20 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,788,899.12. This trade represents a 3.30 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Gary S. Guthart sold 18,151 shares of the business’s stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the sale, the chief executive officer now owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. This trade represents a 42.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 42,453 shares of company stock worth $22,059,506 over the last 90 days. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $584.05 on Monday. The company’s fifty day moving average price is $547.16 and its 200 day moving average price is $504.78. The stock has a market capitalization of $208.03 billion, a P/E ratio of 93.90, a P/E/G ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00.

Analyst Upgrades and Downgrades

ISRG has been the subject of several research analyst reports. BTIG Research raised their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Robert W. Baird upped their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Mizuho raised their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Finally, JPMorgan Chase & Co. upped their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday. One research analyst has rated the stock with a sell rating, three have issued a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $583.83.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.